title: Reply to the letter to the editor 'What is the clinical impact of the LUX-Lung 5 trial?' by Addeo.
authors.affiliation: West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen; German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany. Electronic address: martin.schuler@uk-essen.de.
authors.forename: M
authors.initials: M
authors.lastname: Schuler
authors.affiliation: Department of Medical Research, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan.
authors.forename: J C-H
authors.initials: JC
authors.lastname: Yang
authors.affiliation: Department of Medical Oncology, Gustave Roussy, Villejuif, France.
authors.forename: D
authors.initials: D
authors.lastname: Planchard
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung; D006801:Humans; D008168:Lung; D008175:Lung Neoplasms